Site US11 — Chicago, Illinois

Site US11 is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Site US11 has participated in 1 clinical trials.

Therapeutic areas: Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS.

Sponsors: Astellas Pharma Inc.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US11?

Site US11 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US11 conducted?

Site US11 has 1 clinical trials on record. Their work covers Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS.

Is Site US11 accredited by Crixeo Health?

Site US11 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US11?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.